lifestyle.longislandreport.org

Author: Edison Oncology Holding Corp.

Edison Oncology Completes Target Enrollment in Phase 1/2a Orotecan(TM) Clinical Trial

March 20, 2026
Edison Oncology to Present Two Posters at the 2026 AACR Annual Meeting

March 18, 2026